
Pharmacally
Genmab
Approvals, trial readouts, research and drug safety alerts, interpreted by pharmacists and checked against the primary source.
Latest in Genmab
Health TidingsGenmab Reports Significant Survival Benefit in LiGeR-HN1 TrialGenmab’s Phase 3 LiGeR-HN1 trial met both overall survival and objective response rate endpoints for petosemtamab plus pembrolizumab in first-line PD-L1-positive recurrent or metastatic head and neck squamous…Fact-Checked
Health TidingsGenmab Advances Rina-S Combination After Clean Safety ReadoutPhase 1/2 RAINFOL-01 results show Rina-S combined with bevacizumab was tolerable in recurrent ovarian cancer, supporting continued late-stage development of the FRα-targeted ADC.Fact-Checked
Explore more
Health TidingsIndustry, pipeline and company news.
RegulatoryApprovals, policy and agency decisions.
ResearchPeer-reviewed studies and scientific breakthroughs.
Drug FinderLook up any drug: uses, dosing and safety.
From the HistoryLandmark moments in pharmaceutical history.
LatestEvery new story, as soon as it is published.